Conference abstract · 11 Aug 2015
Conference abstract
Ultra-small nanoparticles of pegylated deoxycholic acid conjugated polyhydroxybutyrate block copolymers for targeted delivery of therapeutics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We have employed the solvent-diffusion and solvent evaporation technique to produce, for the first time, ultra-small nanoparticles (NPs) (<10 nm size) of PEGylated deoxycholic acid conjugated polyhydroxybutyrate block copolymers (DOCAPHB- PEG) by trans-esterification reaction. These devices were capable of encapsulating hydrophobic (e.g., 5-fluorouracil) and hydrophilic (e.g., insulin) drugs and delivering these to the colon after suitably coating with Eudragit S100. Cellular uptake of these NPs after attachment of fluorophore was demonstrated in order to enable a better understanding of the effect of ultrasmall size on the NP transport to the cells with low cytotoxicity as demonstrated by the hyperspectral imaging and confocal live cell imaging, both of which revealed that FITC?insulin labeled NPs showed higher time-dependant cellular uptake. In vitro release kinetics of insulin from these devices in pH 1.2 media for 2 h, followed by pH 7.4 up to 24 h was investigated. The in vivo pharmacokinetic (PK) and pharmacodynamic (PD) studies in streptozotocin induced diabetic rat model revealed their controlled release characteristics. These enteric coated NP formulations were capable of maintaining the blood glucose levels for up to 24 h and are proved to be suitable for transmucosal delivery of insulin and/or anticancer drugs to the colon. The advantages of these NPs are that they exhibit excellent potential in delivering intra-cellular therapeutics. Our recent data will be discussed with specific examples of the steps involved in the preparation of NPs and understanding their delivery profiles for 5-fluorouracil and insulin to the colon.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 30 Sep 2024
Strategies for Non-Covalent Attachment of Antibodies to PEGylated Nanoparticles for Targeted Drug Delivery
Conference abstract
Targeting the notch signaling pathways of hepatocarcenoma and glioblastoma multiform using ultra small iron oxide nanoparticles conjuagated gamma secretase inhibitor
Article · 3 May 2019
Ligand conjugated tumor targeted nanoparticle drug delivery system of vincristine: 32 Full factorial design and in vitro evaluation.
Conference abstract · 20 Feb 2017
Doxorubicin conjugated Fe3 O4 -GQD nanoparticle for magnetically targeted and ph responsive drug delivery vehicle: a two way targeted approach
More from this journal
The newest in Pharmaceutica Analytica Acta.
Article · 16 Sep 2026
The Fc Domains in the Monoclonal Antibody and Fusion Protein Significantly Boost the Biocomposite Suspension's Power to Combat Harmful Microorganisms, Enhance Drug Delivery, and Improve Protein Stability
Article · 26 Jun 2026
Green Pathways in Drug Quality Assessment: The Growing Role of Sustainable Pharmaceutical Analytics
Article · 26 Jun 2026
Advanced Single-Cell Signal Analysis: The Role of Ghost Cytometry in Cell Therapy Characterization
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Tejraj M Aminabhavi”

